Sunshine Biopharma Inc (SBFM)
0.982
+0.14
(+16.90%)
USD |
NASDAQ |
May 06, 16:00
0.988
+0.01
(+0.61%)
After-Hours: 20:00
Sunshine Biopharma Gross Profit Margin (Quarterly): 33.44% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.44% |
| September 30, 2023 | 33.41% |
| June 30, 2023 | 35.12% |
| March 31, 2023 | 37.35% |
| December 31, 2022 | 37.85% |
| September 30, 2022 | 50.47% |
| June 30, 2022 | 50.31% |
| March 31, 2022 | 51.20% |
| December 31, 2021 | 28.00% |
| September 30, 2021 | 61.28% |
| June 30, 2021 | 64.98% |
| March 31, 2021 | 53.77% |
| Date | Value |
|---|---|
| December 31, 2020 | 62.65% |
| September 30, 2020 | 63.03% |
| June 30, 2020 | 65.92% |
| March 31, 2020 | 65.02% |
| December 31, 2019 | 60.35% |
| September 30, 2019 | 27.75% |
| June 30, 2019 | 51.86% |
| March 31, 2019 | 45.63% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -10.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
27.75%
Minimum
Sep 2019
65.92%
Maximum
Jun 2020
49.15%
Average
51.20%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.99% |
| Return on Assets | -16.13% |
| Return on Invested Capital | -20.99% |
| Profit Margin (Quarterly) | -16.28% |
| Operating Margin (Quarterly) | -15.46% |
| Return on Net Operating Assets | -27.55% |